TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34927391

Group type: EXPERIMENTAL
Intervention: Intensive serum urate target of <0.20 mmoles/liter
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard target of <0.30 mmoles/liter
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Intensive target group
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard target group
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 104
Study: 34419564

Group type: EXPERIMENTAL
Intervention: PET-based BMS-IG-IMRT
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard IMRT
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Combined cohort (PET-BMS-IMRT and IMRT)
Number of subjects: 101
Study: 32402585

Group type: EXPERIMENTAL
Intervention: Low-energy high pasta (HP) diet
Number of subjects: 49

Group type: COMPARATOR
Intervention: Low-energy low pasta (LP) diet
Number of subjects: 49
Study: 35584623

Group type: EXPERIMENTAL
Intervention: Urolithin A (Mitopure)
Number of subjects: 0
Study: 33245130

Group type: EXPERIMENTAL
Intervention: Low-dairy diet (<1 serving dairy/d)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Adequate-dairy diet (3-4 servings dairy/d)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Weight loss (both diets)
Number of subjects: 65
Study: 32600919

Group type: EXPERIMENTAL
Intervention: Lapatinib plus Capecitabine (lap-cap)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Trastuzumab plus Capecitabine (tras-cap)
Number of subjects: 30
Study: 35736394

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 2727

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2727
Study: 33245439

Group type: EXPERIMENTAL
Intervention: 25(OH) vitamin D levels (specifically SNP rs12785878)
Number of subjects: 20183

Group type: COMPARATOR
Intervention: None (reverse analysis)
Number of subjects: 20183
Study: 34963069

Group type: EXPERIMENTAL
Intervention: Partner delivered relaxation massage
Number of subjects: 44

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 44
Study: 33801641

Group type: EXPERIMENTAL
Intervention: Red-fleshed apple
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (white-fleshed apple)
Number of subjects: 25
Study: 33373036

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg/day for six months
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 34415638

Group type: EXPERIMENTAL
Intervention: modified mindfulness‐based stress reduction (mMBSR), n = 120
Number of subjects: 246

Group type: COMPARATOR
Intervention: waitlist control group, n = 123
Number of subjects: 246
Study: 33641940

Group type: EXPERIMENTAL
Intervention: Drainage
Number of subjects: 142

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 142
Study: 32144165

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (DAPA) 10 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 34220519

Group type: EXPERIMENTAL
Intervention: HOT-1010
Number of subjects: 84

Group type: COMPARATOR
Intervention: Avastin®
Number of subjects: 84
Study: 32229754

Group type: EXPERIMENTAL
Intervention: Olanzapine 10 mg
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 34164999

Group type: EXPERIMENTAL
Intervention: Advance Care Planning (ACP)
Number of subjects: 200
Study: 33091219

Group type: EXPERIMENTAL
Intervention: Endoscopic submucosal dissection
Number of subjects: 98

Group type: COMPARATOR
Intervention: Transanal endoscopic microsurgery
Number of subjects: 98
Study: 33025002

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens
Number of subjects: 27347

Group type: COMPARATOR
Intervention: Combined estrogens plus progestin
Number of subjects: 27347
Study: 32883567

Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg/day, n = 31)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Standard therapy (n = 18)
Number of subjects: 51
Study: 33724356

Group type: EXPERIMENTAL
Intervention: Hospital admissions (HA)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Emergency department presentations (ED)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Cost of hospital admissions (HA)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Cost of emergency department presentations (ED)
Number of subjects: 1000
Study: 32444045

Group type: EXPERIMENTAL
Intervention: Mediterranean diet for 10 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 80
Study: 35842614

Group type: EXPERIMENTAL
Intervention: Using Novel Implementation Tools for Evidence-based intervention Delivery (UNITED) with Mind the Gap (MTG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Using Novel Implementation Tools for Evidence-based intervention Delivery (UNITED) with Remaking Recess (RR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Using Novel Implementation Tools for Evidence-based intervention Delivery (UNITED) with Self-Determined Learning Model of Instruction (SDLMI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Using Novel Implementation Tools for Evidence-based intervention Delivery (UNITED)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group without UNITED
Number of subjects: 0
Study: 34020345

Group type: EXPERIMENTAL
Intervention: Adjunctive therapy (Flunarizine) on standardized IS treatment
Number of subjects: 41
Study: 32005332

Group type: EXPERIMENTAL
Intervention: Computerized anxiety-insomnia intervention
Number of subjects: 61

Group type: COMPARATOR
Intervention: Physical health control condition
Number of subjects: 61
Study: 33685898

Group type: EXPERIMENTAL
Intervention: Biapenem 250 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Biapenem 1250 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Biapenem 1000 mg
Number of subjects: 36
Study: 32525222

Group type: EXPERIMENTAL
Intervention: Active bilateral anodal transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal cortex (DLPFC) for 10 days
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham bilateral anodal transcranial direct current stimulation (tDCS)
Number of subjects: 33
Study: 32412181

Group type: EXPERIMENTAL
Intervention: Live lecture (45 min)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Videos (45 min)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both groups (live lecture and videos)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Photograph analysis
Number of subjects: 45
Study: 35101133

Group type: EXPERIMENTAL
Intervention: SHARP + usual home care
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 60
Study: 32393616

Group type: EXPERIMENTAL
Intervention: Acupuncture for insomnia with short sleep duration
Number of subjects: 0
Study: 35248737

Group type: EXPERIMENTAL
Intervention: Connected monitoring using a smartphone interface
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Connected monitoring
Number of subjects: 89

Group type: COMPARATOR
Intervention: Conventional monitoring
Number of subjects: 89
Study: 32064652

Group type: EXPERIMENTAL
Intervention: Near-infrared PBM (830 nm and 55 mW/cm2) for 5 minutes
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Red light PBM (633 nm and 70 W/cm2) for 5 minutes
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Responders (10 out of 20 participants) identified by thermal imaging
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Non-responders
Number of subjects: 20
Study: 35040231

Group type: EXPERIMENTAL
Intervention: Nutritional supplements
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebos
Number of subjects: 0
Study: 35799121

Group type: EXPERIMENTAL
Intervention: Enhanced adherence counselling and biofeedback (using urine tenofovir tests for biofeedback) and rapid PrEP collection
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Enhanced counseling and biofeedback plus rapid PrEP collection
Number of subjects: 650

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 650

Group type: COMPARATOR
Intervention: Community PrEP delivery with HIV self-testing
Number of subjects: 650
Study: 32367561

Group type: EXPERIMENTAL
Intervention: Immediate periodontal therapy (oral hygiene instructions and single-visit scaling and root planing)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Delayed periodontal treatment (control group)
Number of subjects: 140
Study: 34420834

Group type: EXPERIMENTAL
Intervention: Zonisamide 25 mg/day
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Zonisamide 50 mg/day (flexible dosing)
Number of subjects: 335

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 335
Study: 33600189

Group type: EXPERIMENTAL
Intervention: l-homocysteine aptamer (randomized SELEX)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: l-homocysteine selection (redirected SELEX)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: original DNA library (original SELEX)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Truncated aptamer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spiegelmer derived from truncated sequence
Number of subjects: 0
Study: 36269355

Group type: EXPERIMENTAL
Intervention: Novel brief motivational intervention (in-person discussion and up to 3 booster telephone calls)
Number of subjects: 344

Group type: COMPARATOR
Intervention: Control group (brief advice)
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Novel brief motivational intervention
Number of subjects: 344
Study: 34508364

Group type: EXPERIMENTAL
Intervention: Fixed CPAP
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Auto‐adjusting Pressure (APAP)
Number of subjects: 46
Study: 34474590

Group type: EXPERIMENTAL
Intervention: Teprasiran (10 mg/kg single dose)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study: 32980764

Group type: EXPERIMENTAL
Intervention: Hyperbaric ropivacaine (9.5, 11, 12.5, 14, or 15.5 mg)
Number of subjects: 200
Study: 35821400

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation (CR) programme for 2 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no cardiac rehabilitation)
Number of subjects: 50
Study: 35801003

Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitors (PPIs)
Number of subjects: 208188
Study: 35862166

Group type: EXPERIMENTAL
Intervention: 3D MOT training
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control task
Number of subjects: 31
Study: 33798028

Group type: EXPERIMENTAL
Intervention: Higher trait mindfulness scores
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Trait mindfulness
Number of subjects: 70
Study: 32533949

Group type: EXPERIMENTAL
Intervention: OMDI 0.002%
Number of subjects: 190

Group type: COMPARATOR
Intervention: Latanoprost 0.005%
Number of subjects: 190
Study: 34980198

Group type: EXPERIMENTAL
Intervention: Sildenafil (25 mg orally three times a day for seven days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (identical capsules, same dosage and duration)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 40
Study: 36342059

Group type: EXPERIMENTAL
Intervention: Mindfulness therapy (8-week face-to-face group program)
Number of subjects: 60
Study: 34404324

Group type: EXPERIMENTAL
Intervention: Neural mobilization (NM)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Neural mobilization through mirror therapy (MT)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Neural mobilization through action observation (AO) training
Number of subjects: 54

Group type: COMPARATOR
Intervention: Classic rehabilitation program (mobility and strength) exercises
Number of subjects: 54
Study: 32740192

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 33421650

Group type: EXPERIMENTAL
Intervention: Digital training (DGT)
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Digital training combined with individualized coaching support (DGT+)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Conventional face-to-face training (F2F)
Number of subjects: 336
Study: 616119841

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab plus PRP
Number of subjects: 125

Group type: COMPARATOR
Intervention: PRP only
Number of subjects: 125
Study: 32758384

Group type: EXPERIMENTAL
Intervention: early parenteral nutrition (early-PN)
Number of subjects: 786

Group type: COMPARATOR
Intervention: late parenteral nutrition (late-PN)
Number of subjects: 786
Study: 32400499

Group type: EXPERIMENTAL
Intervention: subharmonic complemented discrete Fourier transformation (DFT) method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: sparse spectrum (SS) technique
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: sparse spectrum technique with uniform wave vectors (SU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: randomized DFT technique
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: optimization-based (OB) method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 36197173

Group type: EXPERIMENTAL
Intervention: Mind mapping combined with PBL teaching
Number of subjects: 89

Group type: COMPARATOR
Intervention: Traditional lecture-based learning
Number of subjects: 89
Study: 32634624

Group type: EXPERIMENTAL
Intervention: Biennial fecal occult blood test (FOBT) screening
Number of subjects: 108484

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 108484
Study: 33100184

Group type: EXPERIMENTAL
Intervention: Physical activity‐only intervention (PA‐only)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical activity plus fatigue self-management intervention (FM+)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Contact-control intervention (CC)
Number of subjects: 0
Study: 34130556

Group type: EXPERIMENTAL
Intervention: Written benefit finding (three consecutive days of writing about positive thoughts and feelings)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control (unemotively describe the events of the previous day)
Number of subjects: 91
Study: 33444161

Group type: EXPERIMENTAL
Intervention: Insulin Glargine 300 units · mL-1 (Gla-300)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Insulin Degludec 100 units · mL-1 (Deg-100)
Number of subjects: 22
Study: 35643381

Group type: EXPERIMENTAL
Intervention: Shen-Yuan-Dan (SYD) capsules (4 capsules, 3 times a day, with a further 4 capsules 2 hours before PCI)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Shen-Yuan-Dan (SYD) capsules
Number of subjects: 181
Study: 34396512

Group type: EXPERIMENTAL
Intervention: Uterine artery closure at the origin from the internal iliac artery (n=90)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Uterine artery closure at the uterus level (n=90)
Number of subjects: 180
Study: 32542356

Group type: EXPERIMENTAL
Intervention: Trunk Training
Number of subjects: 39

Group type: COMPARATOR
Intervention: Cognitive Training
Number of subjects: 39
Study: 34636853

Group type: EXPERIMENTAL
Intervention: UV-C light plus standard environmental cleaning
Number of subjects: 302

Group type: COMPARATOR
Intervention: Standard environmental cleaning (Control)
Number of subjects: 302
Study: 32422234

Group type: EXPERIMENTAL
Intervention: TMPRSS6 rs855791 polymorphism in iron-deficient students
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: TMPRSS6 rs2111833 polymorphism in iron-deficient students
Number of subjects: 108

Group type: COMPARATOR
Intervention: TMPRSS6 rs855791 polymorphism in healthy students
Number of subjects: 108

Group type: COMPARATOR
Intervention: TMPRSS6 rs2111833 polymorphism in healthy students
Number of subjects: 108
Study: 35001671

Group type: EXPERIMENTAL
Intervention: Resistance Training (RG)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Resistance Training with Core Training (RCG)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 38
Study: 32932860

Group type: EXPERIMENTAL
Intervention: Convolutional neuronal networks for classification of gastritis subtypes
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Convolutional neuronal networks for classification of type B gastritis
Number of subjects: 135
Study: 35534778

Group type: EXPERIMENTAL
Intervention: Multiple micronutrient powder (MNP)
Number of subjects: 1704

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1704
Study: 34941543

Group type: EXPERIMENTAL
Intervention: Statistical blog
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Personal narrative blog
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: General medical blogs
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Barriers to accessing care
Number of subjects: 266
Study: 32935565

Group type: EXPERIMENTAL
Intervention: CEUS-guided PCNL
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional ultrasound-guided PCNL
Number of subjects: 56
Study: 32794482

Group type: EXPERIMENTAL
Intervention: Quadruple therapy (triple therapy + colloidal bismuth subcitrate)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Triple therapy (amoxicillin, clarithromycin, and omeprazole)
Number of subjects: 196
Study: 35322563

Group type: EXPERIMENTAL
Intervention: Simethicone
Number of subjects: 30

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 30
Study: 35285657

Group type: EXPERIMENTAL
Intervention: Forward-viewing endoscope
Number of subjects: 692

Group type: COMPARATOR
Intervention: Proximal retroflexion
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 692
Study: 33956476

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 400
Study: 35637453

Group type: EXPERIMENTAL
Intervention: Midwife local implementation leaders
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Doctor local implementation leaders
Number of subjects: 27
Study: 32307124

Group type: EXPERIMENTAL
Intervention: Counseling intervention implemented at the hospital level for firearm storage
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Counseling intervention implemented at the hospital level for medication storage
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Counseling intervention for medication storage after adjusting for time
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Counseling intervention for firearm storage after adjusting for time
Number of subjects: 575
Study: 36124653

Group type: EXPERIMENTAL
Intervention: Hydrogen inhalation and hydrogen dissolved in water
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo air inhalation
Number of subjects: 20
Study: 32109880

Group type: EXPERIMENTAL
Intervention: Frequent carbohydrate ingestion (15 × 5 g every 5 min)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Late bolus carbohydrate ingestion (1 × 75 g after 75 min)
Number of subjects: 6
Study: 34355628

Group type: EXPERIMENTAL
Intervention: Immediate intervention group (IG) - 34 sessions of group singing over 4 months
Number of subjects: 149

Group type: COMPARATOR
Intervention: Wait-list active control group (WLG)
Number of subjects: 149
Study: 34313217

Group type: EXPERIMENTAL
Intervention: Lysergic acid diethylamide (LSD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual-subject model fitting
Number of subjects: 0
Study: 35304280

Group type: EXPERIMENTAL
Intervention: Inhaled ciclesonide
Number of subjects: 217

Group type: COMPARATOR
Intervention: Control
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Ciclesonide
Number of subjects: 217
Study: 32752026

Group type: EXPERIMENTAL
Intervention: Mobile application providing breastfeeding information
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Control group receiving non-breastfeeding information via smartphone app
Number of subjects: 1000
Study: 35931598

Group type: EXPERIMENTAL
Intervention: Povidone iodine (PI) disinfecting solution
Number of subjects: 80
Study: 37458100

Group type: EXPERIMENTAL
Intervention: PADN plus PDE‐5i
Number of subjects: 128

Group type: COMPARATOR
Intervention: Sham plus PDE‐5i
Number of subjects: 128
Study: 34625041

Group type: EXPERIMENTAL
Intervention: Aripiprazole lauroxil (AL) 1064 mg q8wk
Number of subjects: 200

Group type: COMPARATOR
Intervention: Paliperidone palmitate (PP) 156 mg q4wk
Number of subjects: 200
Study: 32988521

Group type: COMPARATOR
Intervention: NC diet (0.22% for 1‐14 D/0.18% for 15‐35 D)
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Phytase supplementation at 5,000 to 10,000 FTU/kg to NC diets
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Phytase supplementation
Number of subjects: 560
Study: 34030187

Group type: EXPERIMENTAL
Intervention: Collimation
Number of subjects: 39

Group type: COMPARATOR
Intervention: Standard fluoroscopy
Number of subjects: 39
Study: 37463582

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 33493608

Group type: EXPERIMENTAL
Intervention: Cookies that were both physically and psychologically anthropomorphized
Number of subjects: 188

Group type: COMPARATOR
Intervention: Cookies that were physically anthropomorphized only
Number of subjects: 188

Group type: COMPARATOR
Intervention: Cookies that were not anthropomorphized
Number of subjects: 188
Study: 34117400

Group type: EXPERIMENTAL
Intervention: Single site phacotrabeculectomy with MMC 0.2 mg/mL
Number of subjects: 108

Group type: COMPARATOR
Intervention: Twin-site phacotrabeculectomy with MMC 0.2 mg/mL
Number of subjects: 108
Study: 34076495

Group type: EXPERIMENTAL
Intervention: Pluchea indica tea (PIT) 1.5g once daily for 12 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo tea
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Camellia sinensis tea (CST) 1.5g once daily for 12 weeks
Number of subjects: 45
Study: 33377218

Group type: EXPERIMENTAL
Intervention: Inhaled nebulised unfractionated heparin (UFH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 33351359

Group type: EXPERIMENTAL
Intervention: Remote consultation (RC) group
Number of subjects: 180

Group type: COMPARATOR
Intervention: Traditional control (TC) group
Number of subjects: 180
Study: 33622510

Group type: EXPERIMENTAL
Intervention: Approach goal-enhanced intervention
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Avoidance goal-enhanced intervention
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: No-goal intervention
Number of subjects: 224

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 224
Study: 33744986

Group type: EXPERIMENTAL
Intervention: ModraDoc006/r 30–20/100–100
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: ModraDoc006/r 30–20/200–100
Number of subjects: 28